Goniothalamin induces apoptosis associated with autophagy activation through MAPK signaling in SK-BR-3 cells

Sukanda Innajak1, Wilawan Mahabusrakum2, Ramida Watanapokasin1

  • 1Department of Biochemistry, Faculty of Medicine, Srinakharinwirot University, Bangkok 10110, Thailand.

Oncology Reports
|March 18, 2016
PubMed

Insights

Goniothalamin, a natural compound, effectively triggers programmed cell death (apoptosis) and autophagy in human breast cancer cells. This dual action suggests its potential as a novel breast cancer therapeutic agent.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Goniothalamin is a bioactive styryl-lactone derived from plants.
  • It exhibits diverse biological activities, including potential anticancer properties.
  • Human breast cancer cell line SK-BR-3 is a relevant model for studying therapeutic efficacy.

Purpose of the Study:

  • To investigate the anticancer effects of goniothalamin on human breast cancer cells (SK-BR-3).
  • To elucidate the molecular mechanisms underlying goniothalamin-induced cell death and survival pathways.

Main Methods:

  • Cell viability assays and morphological analysis for apoptosis.
  • Mitochondrial function assessment using JC-1 staining.
  • Western blotting to analyze protein expression (Bax, Bcl-2, caspases, PARP, JNK, p38, ERK, Akt, Atg proteins, LC3).

Main Results:

  • Goniothalamin induced apoptosis, characterized by nuclear condensation, DNA fragmentation, and apoptotic bodies.
  • It caused mitochondrial dysfunction and altered the Bax/Bcl-2 ratio.
  • Goniothalamin upregulated pro-apoptotic proteins (cleaved caspase-7, -9, PARP) and downregulated anti-apoptotic Bcl-2.
  • Apoptosis was mediated by p-JNK1/2 and p-p38 upregulation and p-ERK1/2, p-Akt downregulation.
  • Autophagy was induced via upregulation of Atg7, Atg12-Atg5, and LC3II.

Conclusions:

  • Goniothalamin promotes apoptosis and induces autophagy in SK-BR-3 cells.
  • The observed effects are linked to specific signaling pathway modulations (p38, JNK, Akt).
  • Goniothalamin shows promise as a potential therapeutic candidate for breast cancer treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.5K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K